Control of Prostate Cancer by Transrectal HIFU in 227 Patients

Slides:



Advertisements
Similar presentations
Volume 53, Issue 3, Pages (March 2008)
Advertisements

Volume 71, Issue 2, Pages (February 2017)
The PSA Era is not Over for Prostate Cancer
Volume 59, Issue 2, Pages (February 2011)
Volume 50, Issue 1, Pages (July 2006)
Volume 51, Issue 2, Pages (February 2007)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 44, Issue 6, Pages (December 2003)
Volume 58, Issue 4, Pages (October 2010)
Prostate Cancer: Highlights from 2006
Volume 49, Issue 2, Pages (February 2006)
Volume 53, Issue 5, Pages (May 2008)
Volume 65, Issue 5, Pages (May 2014)
Volume 70, Issue 2, Pages (August 2016)
Volume 71, Issue 5, Pages (May 2017)
Hormone Therapy for Prostate Cancer: Exploring Current Controversies
Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?
Volume 71, Issue 2, Pages (February 2017)
Prostate Cancer Epidemic in Sight?
Volume 52, Issue 4, Pages (October 2007)
Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer  Sam Ladjevardi, Gabriel Sandblom,
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 67, Issue 2, Pages (February 2015)
Volume 73, Issue 2, Pages (February 2018)
Volume 71, Issue 1, Pages 1-3 (January 2017)
Volume 61, Issue 5, Pages (May 2012)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Prostate Cancer Detection: A View of the Future
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
Volume 56, Issue 2, Pages (August 2009)
Volume 57, Issue 4, Pages e41-e42 (April 2010)
Laurent Boccon-Gibod  European Urology Supplements 
Volume 64, Issue 6, Pages (December 2013)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Volume 53, Issue 2, Pages (February 2008)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 58, Issue 4, Pages (October 2010)
Volume 53, Issue 6, Pages (June 2008)
Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?  Michel Bolla  European.
Volume 61, Issue 2, Pages (February 2012)
Volume 66, Issue 2, Pages (August 2014)
Volume 58, Issue 1, Pages 1-7 (July 2010)
Volume 63, Issue 3, Pages (March 2013)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 70, Issue 2, Pages (August 2016)
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Volume 50, Issue 2, Pages (August 2006)
Volume 51, Issue 2, Pages (February 2007)
Volume 66, Issue 6, Pages (December 2014)
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Long-Term Hormonal Therapy: Who Would Benefit?
European Urology is “Your” Journal
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
Improving Flexibility and Quality of Life for Your Patients: A Must?
Highlighting Unmet Needs: Real Patients, Difficult Choices
Volume 53, Issue 6, Pages (June 2008)
Management of Prostate Cancer: Global Strategies
Volume 53, Issue 2, Pages (February 2008)
Volume 51, Issue 2, Pages (February 2007)
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Control of Prostate Cancer by Transrectal HIFU in 227 Patients Laura Poissonnier, Jean-Yves Chapelon, Olivier Rouvière, Laura Curiel, Raymonde Bouvier, Xavier Martin, Jean Michel Dubernard, Albert Gelet  European Urology  Volume 51, Issue 2, Pages 381-387 (February 2007) DOI: 10.1016/j.eururo.2006.04.012 Copyright © 2006 Terms and Conditions

Fig. 1 Overall disease-free survival rate. European Urology 2007 51, 381-387DOI: (10.1016/j.eururo.2006.04.012) Copyright © 2006 Terms and Conditions

Fig. 2 (a) Disease-free survival rate in relation to initial PSA level. (b) Disease-free survival rate in relation to Gleason score. (c) Disease-free survival rate in relation to clinical stage. (d) Disease-free survival rate in relation to neoadjuvant hormonal deprivation. (e) Disease-free survival rate depending on procedure. European Urology 2007 51, 381-387DOI: (10.1016/j.eururo.2006.04.012) Copyright © 2006 Terms and Conditions

Fig. 3 Overall actuarial adjuvant treatment-free rate. European Urology 2007 51, 381-387DOI: (10.1016/j.eururo.2006.04.012) Copyright © 2006 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.